11:54 AM EDT, 04/02/2024 (MT Newswires) -- ImmuCell ( ICCC ) shares dropped 2.3% in recent Tuesday trading, a day after the company filed a registration statement for the potential sale of $20 million of securities.

The regulatory shelf filing covers common stock, warrants and subscription rights.

The company said it plans to use the net proceeds for debt repayment, capital expenditures, working capital and general corporate purposes.

Price: 5.12, Change: -0.12, Percent Change: -2.29